Derm Discussions: Recent Episodes
Derm Discussions
Dermatologist and professor Brad Glick, DO, FAAD, leads a monthly conversation with a fellow expert on the trends, news, and musings from the medical field of dermatology.
Last summer, Derm Discussions host Brad Glick, DO, invited Brett King, MD, PhD, Yale School of Medicine, to the program to discuss an emerging class of dermatology therapy known as Janus kinase (JAK) inhibitors.
At the time, small molecule drugs such as upadacitinib (Rinvoq) were approved for the treatment of conditions like rheumatoid arthritis and ulcerative colitis.
Since then, updacacitinib and abrocitinib (Cibinqo) have been approved for use in patients with atopic dermatitis, a skin condition that affects up to 7.3% of adults in the United States alone.
Janus kinase inhibitors modulate the activity of multiple cytokine drivers of atopic dermatitis, and are supported by a variety of positive clinical trial results.
Dr. Glick welcomed Dr. King back to Derm Discussions to provide insight into the role JAK inhibitors play in the ever-growing armamentarium against atopic dermatitis.
Dr. Moody speaks to how the coding changes can aid in streamlining billing documentation for dermatologists.
Brett King, MD, PhD, joins Brad Glick, DO, to discuss the potential of the JAK inhibitor class for dermatology.
Misha Rosenbach, MD, discusses how rising temperatures and climate change, issues of public health concern, are relevant to the field of dermatology.
Rebecca Kazin, MD, offers some insight into her cosmetic dermatology practices, including a new hair product that she developed.
Valerie Callender, MD, draws on her experiences in clinical practice to discuss cosmetic dermatology care practices and the challenges of this past year.
Todd Schlesinger, MD, talks new therapies on the horizon and those that have already proven efficacious.
In this episode of Derm Discussions, Peter Lio, MD, discusses the difficulties treating itch as well as alternative—and perhaps surprising—therapeutic options.
Lisa Swanson, MD, and Brad Glick, DO, FAAD, discuss a wide range of dermatological conditions faced by pediatric patients—from acne to atopic dermatitis, and everything in between.
Seemal Desai, MD, joins Brad Glick, DO, for an update on dermatologic burdens in people of color.
Assistant editor and producer Jonathan Alicea explains what you can expect from the monthly skin health podcast series.